InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Lynch Daniel, 董事. Director active across 4 companies, notably SpringWorks Therapeutics, Inc.. In total, 14 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €6.2m. History available since 20 May 2021. The latest transaction was filed on 14 May 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lynch Daniel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
93,004 股Common StockSEC:0001104659-25-065321:0
10,060 股0Common StockSEC:0001104659-25-049662:0
44,018 股@ US$60.138741.2% 占其流量Common StockSEC:0001104659-25-016614:0
400 股@ US$60.000.4% 占其流量Common StockSEC:0001104659-25-015215:0
69,766 股@ US$53.228758.4% 占其流量Common StockSEC:0001104659-25-012364:0
4,095 股0Common StockSEC:0001104659-24-062992:0
8,400 股0Common StockSEC:0001562180-23-005219:0
4,648 股0Common StockSEC:0001104659-23-064648:0
7,200 股0Common StockSEC:0001562180-22-004992:0
4,818 股0Common StockSEC:0001104659-22-063508:0
00Common StockSEC:0001628280-21-023649:0
2,803 股0Common StockSEC:0001628280-21-023471:0
4,353 股0Common StockSEC:0001562180-21-004349:0
1,106 股0Common StockSEC:0001104659-21-070515:0
14 条申报中的 14 条
About Lynch Daniel
Administrateur of SpringWorks Therapeutics, Inc., 2seventy bio, Inc. and bluebird bio, Inc., LYNCH DANIEL has 14 filings in total. Across the 14 sampled filings, the period covered runs from 2021-05-21 to 2025-07-02, with 0 in buys and 6164510 in sales, mainly in SpringWorks Therapeutics, Inc.
